Literature DB >> 27534257

Transcultural validation of the ALS-CBS Cognitive Section for the Brazilian population.

Lucas M T Branco1, Tamires Zanao1, Thiago J De Rezende1, Raphael F Casseb1, Marcio F Balthazar1, Susan C Woolley2, Marcondes C França1.   

Abstract

Cognitive decline (CD) is common but often under-recognized in ALS due to the scarcity of adequate cognitive screening methods. In this scenario, the Amyotrophic Lateral Sclerosis Cognitive Behavioural Screen (ALS-CBS) is the most investigated instrument and presents high sensitivity to identify CD. Currently, there are no validated cognitive screening tools for ALS patients in the Brazilian population and little is known about the frequency of ALS related CD in the country. We assessed the accuracy of the Brazilian Portuguese version of ALS-CBS Cognitive Section (ALS-CBS-Br) for classifying the cognitive status of Brazilian patients compared to a standard neuropsychological battery, and estimated the prevalence of CD in the Brazilian ALS population. Among 73 initially recruited ALS patients, 49 were included. Twenty-four patients were excluded due to severe motor disability, FTD diagnosis or non-acceptance. Ten healthy controls were also included. Ten ALS patients (20%) were diagnosed with executive dysfunction (ALSci) based on the battery results. ALS-CBS-Br scores were significantly lower in the ALSci group (p < 0.001). The scale accuracy in detecting executive dysfunction was 0.906. Optimal cut-off score was 10/20 (specificity 0.872 and sensitivity 0.900). In conclusion, the ALS-CBS-Br may facilitate the recognition of CD in routine clinical care and complement future studies in our population.

Entities:  

Keywords:  ALS; cognition; motor neuron disease; screening

Mesh:

Substances:

Year:  2016        PMID: 27534257     DOI: 10.1080/21678421.2016.1211147

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  5 in total

1.  Cross-cultural adaptation and validation for the Brazilian population of the instrument Amyotrophic Lateral Sclerosis-Specific Quality of Life-Short Form (ALSSQOL-SF).

Authors:  Maisa Vitória Gayoso; Flávia Seullner Domingues; Marcondes Cavalcante França Junior; Stephanie H Felgoise; Acary Souza Bulle Oliveira; Guilherme Antonio Moreira de Barros
Journal:  Qual Life Res       Date:  2019-10-29       Impact factor: 4.147

2.  ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.

Authors:  Lucio Tremolizzo; Andrea Lizio; Gabriella Santangelo; Susanna Diamanti; Christian Lunetta; Francesca Gerardi; Sonia Messina; Stefania La Foresta; Nilo Riva; Yuri Falzone; Massimo Filippi; Susan C Woolley; Valeria Ada Sansone; Mattia Siciliano; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2019-12-05       Impact factor: 3.307

Review 3.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

Review 4.  Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review.

Authors:  Tina Taule; Margaret Søvik; Regina Küfner Lein; Eike Wehling; Jörg Aßmus; Tiina Rekand
Journal:  Patient Relat Outcome Meas       Date:  2020-09-22

5.  Effects of an optimised approach to home-based respiratory care in individuals with amyotrophic lateral sclerosis: a study protocol for a randomised controlled trial.

Authors:  Karen Pondofe; Guilherme A F Fregonezi; Ozana Brito; Mario Emilio Dourado Júnior; Rodrigo Torres-Castro; Vanessa R Resqueti
Journal:  BMJ Open       Date:  2021-04-09       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.